Tuesday, September 22, 2020 9:21:31 AM
REASON:
#1. AW should have commercialized the initial product for the treatment of post-operative pain relating to eyelid surgery. That would have negated the need for dilutive financing. If done, today's OS would likely be in the millions, not tens of billions.
#2. Major deals were nixed by AW. Was he suffering from dementia, or did he never intend to sell the products? IDK, but I do know that AW killed some great relationships with former BIEL customers.
#3. The funds came from investors buying unregistered shares of BIEL, printed by AW, and granted to IBEX (KW). Not from the Whelan checking account.
4 The financing arrangement enjoyed by the Whelan's was designed largely for the Whelans. For their personal enrichment. It has fed their family for 20-years AND given them the potential to own nearly 2/3rds of our company. They've benefited from this loan program more than anyone else. It was not publically touted to the investment community. Rather, it was kept mainly under wraps and used by insiders.
HOW MUCH MONEY DID BORROWING FROM THE WHELAN FAMILY ACTUALLY BRING BIEL?
#5. The terms of the convertible promissory notes are horrible for BIEL. Less dilutive financing could have been put in place.
All of my comments are based on my own due diligence and are only my opinion. Please conduct your own due diligence and research before deciding whether to buy or sell any stock. My posts are for entertainment only.
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM